Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate medications, this sort of devices like a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and comprise